CellProthera-preview

Cellprothera

CellProthera

Private

MulhouseHealthcare & Life Scienceshttps://www.cellprothera.com/en/home/

Last Round

VC Round

Mar 30, 2023

Total Funding Raised

$22.64M

Momentum Score

25 /100

Company Overview

CellProthera is a biotechnology company that develops regenerative cell therapy for the structural and functional regeneration of cardiac lesions following a severe heart attack.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Clinical Trials, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

regenerative cell therapyautologous cell therapycardiac cell therapyheart attack therapystem cell therapyautomated cell expansioncardiac regenerationclinical stage biotechCD34+ stem cellsheart failure therapyrazor and blade modelcell therapy manufacturingacute myocardial infarctionAMIbiotech equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CellProthera Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CellProthera Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Mar 30, 2023
Grant	May 1, 2018
VC Round	Sep 3, 2014
Grant	Jul 11, 2013
Seed	Sep 1, 2009

View all Funding Rounds

Key People

Founding team and executive leadership

Olivier Friedrich

Directeur Adm. & Financier - CFO DRH

Executive Team

Jean-Olivier HIRSCH

Chief Operating Officer, Quality And Regulatory Aff. Director - Qualified Person

Executive Team

CellProthera Investors

Notable investors and investment history

Investor	Rounds
Horizon 2020	Grant
Alsace Business Angels	VC Round, Seed
SODIV	VC Round
Bpifrance	VC Round, Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 22, 2026
Grew 32% QoQ, from 22 to 29 employees.
Jan 5, 2026
Monthly visitors increased 63% MoM, reaching 4K.

View all signals

CellProthera Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

CellProthera Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CellProthera's valuation, stock price, and market status.

Firmographic Details

HeadquartersMulhouse

Employee Range29

Year Founded2008

Last FundingMar 30, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.